Showing posts with label Prednisolone. Show all posts
Showing posts with label Prednisolone. Show all posts

Monday, 24 February 2025

Prevalence, Pregnancy Outcomes and Treatment Modalities of Immune Thrombocytopenia Mothers Over 5-years in a Tertiary Health Care Hospital in South India | Chapter 15 | Achievements and Challenges of Medicine and Medical Science Vol. 11

Background: It has been proposed that thrombocytopenia is the most common haematological abnormality in pregnancy after anaemia. The incidence of severe immune thrombocytopenia (ITP) in pregnancy has been difficult to report because of the rarity of the disease. Treating pregnancy associated with ITP can be difficult.

Objective: The objectives were to determine the prevalence, pregnancy outcomes, and treatment modalities of ITP mothers over five years in a tertiary health care hospital in South India.

Methods: Our study was a retrospective record study, which looked into various aspects of obstetrical outcomes and complications in ITP mothers. Records of the in-patient medical record department (MRD) folders of patients with ITP who delivered at St. Johns Medical Hospital, Bangalore were studied. Patients with acute and chronic ITP were included as per the Vicenza consensus conference and the criteria for differentiating primary from secondary forms of ITP was followed, with consideration of a new entity of ITP associated with the presence of antiphospholipid antibodies.

Results: The study identified 53 patients with ITP with a mean age of 25.6+4.6 years, age of diagnosis of ITP at 21.1+5.9 years and gestational age of 36.2+3 weeks. In our study 17 (32%) were acute and 36 (67.1%) were chronic ITP. In our study, 39.6% had a history of at least one prior pregnancy loss. Patients with ITP at 35-37 weeks were induced with PGE1 (35.7%) in comparison to those with PGE2 (p≤0.001). Post-partum haemorrage (PPH) was seen in 7.5% of the pregnancies and all four were mothers with chronic ITP. Severe preeclampsia in ITP mothers was seen in 2 (66.7%).  All the findings showed that there is no reliable maternal parameter to predict the susceptibility and the need for intervention in mothers with life-threatening thrombocytopenia and the complications it poses to the foetus. Hence, constant vigilance is required to establish a safe pregnancy outcome in mothers with ITP.

Conclusions: Chronic ITP in pregnancy poses more risks to mother and foetus as seen with the higher chance of PPH etc. Mothers with ITP should be screened antenatally as the chances of anomalies are high in the foetus.

 

Author (s) Details

 

Shashikala Karanth
Department of Obstetrics and Gynecology, St. John’s Medical College and Hospital, Bangalore, Karnataka, India.

 

Christy Vijay
Department of Obstetrics and Gynecology, St. John’s Medical College and Hospital, Bangalore, Karnataka, India.

 

Chaitanya Harita
Department of Medicine, St. John’s Medical College and Hospital, Bangalore, Karnataka, India.

 

Jaya S. Mol
Department of Obstetrics and Gynecology, St. John’s Medical College and Hospital, Bangalore, Karnataka, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/acmms/v11/3758

Thursday, 12 August 2021

An Advanced Study on Development and Validation of RP-HPLC Method for Simultaneous Estimation of Mesalamine and Prednisolone in Bulk and Formulation | Chapter 1 | Technological Innovation in Pharmaceutical Research Vol. 9

 A simple, precise, accurate, sensitive, and economical reversed phase high performance liquid chromatographic method for the simultaneous determination of Mesalamine (MSL) and Prednisolone (PRD) in combined dosage forms was developed and validated in accordance with the analytical parameter mentioned in the ICH guidelines. The drugs were separated using chromatography on a C-18 Phenomenex column (250 mm 4.6 mm i.d.) with an acetonitrile:phosphate buffer (20:80 v/v) mobile phase (pH adjusted to 6 with Orthophosphoric acid). The detection was carried out in a 330 nm is the wavelength. The retention times for Mesalamine and Prednisolone were 4.373 minutes and 1.589 minutes, respectively. Meselamine was found to be linear in the range of 5-25 g/ml, and Prednisolone was found to be linear in the range of 2-10 g/ml. Mesalamine and Prednisolone were shown to have recovery rates of 99.57 percent and 100.63 percent, respectively. Mesalamine has a correlation coefficient of 0.9973, whereas Prednisolone has a correlation coefficient of 0.9984. With a smaller RSD, the approach demonstrated appropriate precision (less than 1 percent ).


Author (s) Details

Ms. N. K. Drisya
Department of Pharmaceutical Analysis, Al Shifa College of Pharmacy, Perinthalmanna, Kerala, 679325, India.

Dr. S. S. Prasanth
Department of Pharmaceutical Analysis, Al Shifa College of Pharmacy, Perinthalmanna, Kerala, 679325, India.

Mrs. V. Akhila
Department of Pharmaceutical Analysis, Al Shifa College of Pharmacy, Perinthalmanna, Kerala, 679325, India.

Mrs. K. Sruthi
Department of Pharmaceutical Analysis, Al Shifa College of Pharmacy, Perinthalmanna, Kerala, 679325, India.

View Book :- https://stm.bookpi.org/TIPR-V9/article/view/2514